Squarepoint
OXFD

Squarepoint’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Squarepoint’s Portfolio OXFD Stock Details OXFD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-15,600
Closed -$203K – 2998
2020
Q2 		$203K Sell
15,600
-44,503
-74% -$535K ﹤0.01% 1821
2020
Q1 		$557K Sell
60,103
-21,811
-27% -$305K 0.01% 975
2019
Q4 		$1.36M Buy
81,914
+28,586
+54% +$464K 0.01% 1143
2019
Q3 		$887K Sell
53,328
-11,315
-18% -$156K 0.01% 1316
2019
Q2 		$889K Buy
64,643
+22,697
+54% +$347K 0.01% 1329
2019
Q1 		$723K Buy
41,946
+22,643
+117% +$358K 0.01% 1275
2018
Q4 		$247K Buy
19,303
+5,120
+36% +$77.7K ﹤0.01% 1595
2018
Q3 		$230K Buy
14,183
+3,023
+27% +$43.2K ﹤0.01% 1690
2018
Q2 		$144K Buy
+11,160
New +$151K ﹤0.01% 1594

Other funds holding OXFD

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
GPGA
Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.29B AUM 53.44% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Squarepoint's OXFD Position: Q3 2020 in Review

Squarepoint sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q3 2020, closing a stake of 15,600 shares — an estimated $203K sold.

Squarepoint first reported a position in OXFD in Q2 2018 and held it in 9 quarters. The position peaked at $1.36M in Q4 2019. 71 funds tracked by Wall St. Rank hold OXFD as of Q3 2020.

  • Squarepoint reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q3 2020 after selling out during the quarter.
  • Squarepoint sold 15,600 Oxford Immunotec Global PLC Ordinary Shares shares in Q3 2020, an estimated $203K.
  • Squarepoint first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q2 2018 and held it in 9 quarters.
  • Squarepoint's Oxford Immunotec Global PLC Ordinary Shares position peaked at $1.36M in Q4 2019.
  • 71 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q3 2020.

Based on Squarepoint's 13F filing for Q3 2020, filed 16 Nov 2020.